LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | AZD7762 | 3.33 | uM | LJP6 | 3 | L02 | 72 | hr | 1209 | 992 | 4121 | 0.2407 | -0.1061 |
| MCF7 | AZD7762 | 10 | uM | LJP6 | 1 | L01 | 72 | hr | 1209 | 689 | 3823 | 0.1802 | -0.2875 |
| MCF7 | AZD7762 | 10 | uM | LJP6 | 2 | L01 | 72 | hr | 1209 | 614 | 4093 | 0.1500 | -0.3199 |
| MCF7 | AZD7762 | 10 | uM | LJP6 | 3 | L01 | 72 | hr | 1209 | 549 | 4121 | 0.1332 | -0.3602 |
| MCF7 | AZD8055 | 0.04 | uM | LJP6 | 1 | A12 | 72 | hr | 1209 | 1100 | 3823 | 0.2877 | -0.0556 |
| MCF7 | AZD8055 | 0.04 | uM | LJP6 | 2 | A12 | 72 | hr | 1209 | 1244 | 4093 | 0.3039 | 0.0161 |
| MCF7 | AZD8055 | 0.04 | uM | LJP6 | 3 | A12 | 72 | hr | 1209 | 1254 | 4121 | 0.3043 | 0.0206 |
| MCF7 | AZD8055 | 0.12 | uM | LJP6 | 1 | A11 | 72 | hr | 1209 | 1087 | 3823 | 0.2843 | -0.0623 |
| MCF7 | AZD8055 | 0.12 | uM | LJP6 | 2 | A11 | 72 | hr | 1209 | 1102 | 4093 | 0.2692 | -0.0516 |
| MCF7 | AZD8055 | 0.12 | uM | LJP6 | 3 | A11 | 72 | hr | 1209 | 1137 | 4121 | 0.2759 | -0.0344 |
| MCF7 | AZD8055 | 0.37 | uM | LJP6 | 1 | A10 | 72 | hr | 1209 | 1013 | 3823 | 0.2650 | -0.1013 |
| MCF7 | AZD8055 | 0.37 | uM | LJP6 | 2 | A10 | 72 | hr | 1209 | 1039 | 4093 | 0.2538 | -0.0828 |
| MCF7 | AZD8055 | 0.37 | uM | LJP6 | 3 | A10 | 72 | hr | 1209 | 1039 | 4121 | 0.2521 | -0.0824 |
| MCF7 | AZD8055 | 1.11 | uM | LJP6 | 1 | A09 | 72 | hr | 1209 | 1059 | 3823 | 0.2770 | -0.0769 |
| MCF7 | AZD8055 | 1.11 | uM | LJP6 | 2 | A09 | 72 | hr | 1209 | 1113 | 4093 | 0.2719 | -0.0462 |
| MCF7 | AZD8055 | 1.11 | uM | LJP6 | 3 | A09 | 72 | hr | 1209 | 900 | 4121 | 0.2184 | -0.1539 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 1 | A08 | 72 | hr | 1209 | 957 | 3823 | 0.2503 | -0.1316 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 2 | A08 | 72 | hr | 1209 | 1002 | 4093 | 0.2448 | -0.1015 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 3 | A08 | 72 | hr | 1209 | 997 | 4121 | 0.2419 | -0.1035 |
| MCF7 | AZD8055 | 10 | uM | LJP6 | 1 | A07 | 72 | hr | 1209 | 370 | 3823 | 0.0968 | -0.5101 |
| MCF7 | AZD8055 | 10 | uM | LJP6 | 2 | A07 | 72 | hr | 1209 | 386 | 4093 | 0.0943 | -0.4776 |
| MCF7 | AZD8055 | 10 | uM | LJP6 | 3 | A07 | 72 | hr | 1209 | 409 | 4121 | 0.0992 | -0.4583 |
| MCF7 | Sorafenib | 0.04 | uM | LJP6 | 1 | B12 | 72 | hr | 1209 | 3591 | 3823 | 0.9393 | 0.9260 |
| MCF7 | Sorafenib | 0.04 | uM | LJP6 | 2 | B12 | 72 | hr | 1209 | 3746 | 4093 | 0.9150 | 0.9015 |
| MCF7 | Sorafenib | 0.04 | uM | LJP6 | 3 | B12 | 72 | hr | 1209 | 3898 | 4121 | 0.9458 | 0.9380 |